14th International Workshop on Ataxia-Telangiectasia and ATM
第14届共济失调毛细血管扩张与ATM国际研讨会
基本信息
- 批准号:7805688
- 负责人:
- 金额:$ 4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:ATM geneATM wt AlleleAllelesAnimal ModelAreaAtaxia TelangiectasiaBiologyBreastCell Cycle CheckpointCell LineCellsCerebellar AtaxiaChromatinClinicalClinical TrialsCollaborationsComplexDNA DamageDNA Double Strand BreakDNA IntegrationDevelopmentDiseaseDrug Delivery SystemsEducational workshopFamilyFunding ApplicantFutureGeneral PopulationGenomic InstabilityGoalsHereditary DiseaseHeterozygoteHumanImmunologic Deficiency SyndromesIncidenceInheritedInternationalIonizing radiationLeadLearningLogisticsLymphomaMalignant NeoplasmsMolecularMutationNerve DegenerationNervous system structureNeurodegenerative DisordersOther GeneticsOutcomePathogenesisPatientsPharmaceutical PreparationsPhenotypePhosphatidylinositolsPhosphotransferasesPredispositionProtein DeficiencyProtein-Serine-Threonine KinasesProteinsRadiationRadiation ToleranceResearchResearch PersonnelRiskRoleSignal TransductionStudy modelsVirus DiseasesWorkabstractingataxia telangiectasia mutated proteinbasecancer epidemiologycancer riskdesigninterestleukemiamalignant breast neoplasmmeetingsmembernervous system disorderneurodevelopmentneuropathologyplanetary Atmospherepostersrelating to nervous systemrepairedresponserole modelsymposiumweb site
项目摘要
DESCRIPTION (provided by applicant): Funds are requested for partial support towards the 14th International Workshop on Ataxia-Telangiectasia and ATM, which will be held at the Crowne Plaza Hotel in Redondo Beach, CA. on April 11-14, 2010. We expect to invite approximately 60 speakers; half of these will be selected by the Organizing Committee and Co-Chairs of their sessions, while the other half will come from abstracts submitted in response to an AT/ATM-focused list of "Topics of Interest" that will be posted on the conference website. The incoming abstracts will be reviewed by both the Organizing Committee and the Co-Chairs. The remaining abstracts will be presented as posters; there is room for 100 posters. Ataxia-telangiectasia (A-T) is a complex autosomal recessive disorder that is characterized by a progressive cerebellar ataxia, telangiectasia, immunodeficiency, genomic instability, radiation sensitivity, and a markedly increased incidence of cancer, usually lymphoma or leukemia. It has been estimated that 1-6% of the general population carries mutations in one allele of the ATM (ataxia-telangiectasia mutated) gene and ATM heterozygotes have an increased risk of developing breast cancer. The ATM gene encodes a large (369 kDa) protein, ATM, which is a member of the phosphatidyl inositol 3 kinase family of serine/threonine protein kinases. The major role of ATM appears to be in the recognition and repair of double strand DNA breaks, through coordinated cell cycle checkpoint control and signaling to hundreds of downstream targets. Cells that lack ATM are highly sensitive to ionizing radiation (IR) and other DNA damaging agents. Understanding the function of ATM is of considerable importance to understanding the role of ATM in neural development and neurodegeneration, the molecular basis for increased cancer predisposition, and the molecular mechanisms that control how cells respond to radiation damage and radiomimetic chemotherapeutic drugs. A-T has also become a model for the study of mutation-targeted drugs for correcting genetic diseases. Animal models and hundreds of patient-derived cell lines are available, with identified mutations. Objectives of the meeting: The objectives of the meeting are to bring together an international group of basic and clinical researchers working on various aspects of A-T and related neurodegenerative diseases, as well as on the role of ATM in cancer, the DNA damage response, and in viral infections that involve DNA integration. Our goal is to stimulate research that will lead to better understanding and treatment of A-T and other genetic diseases. Specific areas of focus of the meeting will include the role of ATM and related proteins in the DNA damage response, the importance of chromatin and genomic instability in the activation of ATM, the role of ATM in the developing nervous system and in neurodegeneration, animal models of A-T, ATM mutations in breast and other human cancers, the epidemiology of ATM mutations, and the development and design of future clinical trials for A-T patients worldwide. We also hope to encourage new young investigators to develop an interest in both clinical and basic A-T/ATM-related research.
描述(由申请人提供): 请求提供资金,以部分支助将在加利福尼亚州雷东多海滩皇冠假日酒店举行的第14次共济失调-毛细血管扩张症和ATM国际讲习班。2010年4月11日至14日。我们预计将邀请大约60名发言者;其中一半将由组织委员会和会议共同主席挑选,另一半将来自根据将在会议网站上公布的以反洗钱/反洗钱为重点的“感兴趣的议题”清单提交的摘要。收到的摘要将由组织委员会和共同主席审查。其余的摘要将以海报形式展示;可容纳100张海报。共济失调-毛细血管扩张症(A-T)是一种复杂的常染色体隐性遗传疾病,其特征在于进行性小脑共济失调、毛细血管扩张、免疫缺陷、基因组不稳定性、辐射敏感性和癌症(通常为淋巴瘤或白血病)的显著增加的发病率。据估计,1-6%的普通人群携带ATM(共济失调-毛细血管扩张突变)基因的一个等位基因突变,ATM杂合子患乳腺癌的风险增加。ATM基因编码一个大的(369 kDa)蛋白,ATM,它是磷脂酰肌醇3激酶家族的丝氨酸/苏氨酸蛋白激酶的成员。ATM的主要作用似乎是识别和修复双链DNA断裂,通过协调细胞周期检查点控制和信号传导到数百个下游靶点。缺乏ATM的细胞对电离辐射(IR)和其他DNA损伤剂高度敏感。理解ATM的功能对于理解ATM在神经发育和神经变性中的作用、增加癌症易感性的分子基础以及控制细胞如何对辐射损伤和拟放射性化疗药物作出反应的分子机制具有相当重要的意义。A-T也成为研究用于纠正遗传疾病的突变靶向药物的模型。动物模型和数百种患者来源的细胞系是可用的,具有鉴定的突变。会议的目标:会议的目的是汇集一个国际基础和临床研究人员小组,研究A-T和相关神经退行性疾病的各个方面,以及ATM在癌症中的作用,DNA损伤反应,以及涉及DNA整合的病毒感染。我们的目标是促进研究,从而更好地理解和治疗A-T和其他遗传疾病。会议的具体重点领域将包括ATM和相关蛋白在DNA损伤反应中的作用,染色质和基因组不稳定性在ATM激活中的重要性,ATM在发育中的神经系统和神经变性中的作用,A-T的动物模型,乳腺癌和其他人类癌症中的ATM突变,ATM突变的流行病学,以及未来针对全球A-T患者的临床试验的开发和设计。我们还希望鼓励新的年轻研究人员对临床和基础A-T/ATM相关研究产生兴趣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD A GATTI其他文献
RICHARD A GATTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD A GATTI', 18)}}的其他基金
13th International Workshop on Ataxia-Telangiectasia and ATM
第13届共济失调-毛细血管扩张与ATM国际研讨会
- 批准号:
7483575 - 财政年份:2008
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
7640833 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
8094618 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
7874551 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
8090432 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
7316730 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
7681871 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
DRUG-INDUCED ATM READTHROUGH OF PTC MUTATIONS
药物诱导的 ATM 读取 PTC 突变
- 批准号:
7488560 - 财政年份:2007
- 资助金额:
$ 4万 - 项目类别:
12th International Workshop on Ataxia-Telangiectasia and ATM
第十二届共济失调毛细血管扩张与 ATM 国际研讨会
- 批准号:
7163680 - 财政年份:2006
- 资助金额:
$ 4万 - 项目类别: